SHP2的Allosteric调制:从已知的探索到未知的探索
Ning Wang1,2, Shilin Zhu3, Dan Lv1,2,4
1Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, China.
Drug development research
|August 16, 2023
概括
含有Src同质-2域的蛋白质氨酸酸酶-2 (SHP2) 在癌症中至关重要,但其活性部位很难准. 菌抑制剂为开发新的抗瘤药物提供了一个有希望的,更安全的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 含有Src同质-2域的蛋白质氨酸酸酶-2 (SHP2) 是细胞循环的关键调节者.
- 激活SHP2的突变与各种癌症有关,使其成为关键的治疗标.
- 保存的,正电荷的SHP2活性部位对开发高亲和度,细胞透性骨抑制剂提出了挑战,使其成为"不可抗药"的目标.
研究的目的:
- 阐明由SHP2驱动的致癌机制.
- 审查和总结用于发现SHP2全抑制剂的方法.
- 为设计和优化新型SHP2全抑制剂提供见解和策略.
主要方法:
- 文献综述侧重于SHP2在癌症中的作用.
- 分析详细介绍SHP2全抑制剂的发现和特征的研究.
- 探索全性调节作为一种治疗策略.
主要成果:
- 证实了SHP2在瘤发生中的关键作用.
- 体抑制成为克服向SHP2活性部位的局限性的可行替代方案.
- 该审查巩固了SHP2全抑制剂的各种发现方法.
结论:
- 与orthosteric抑制剂相比,allosteric抑制是一种更有选择性和更安全的方法来准SHP2.
- 了解SHP2的全调节,为癌症治疗开辟了新的途径.
- 本综述为推进SHP2全抑制剂开发提供了一个战略框架.
相关概念视频
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Allosteric Regulation
58.2K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
58.2K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Assembly of Signaling Complexes
5.8K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.8K
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K


